$472.16 pre-market ISRG Intuitive Surgical NASDAQ Mar 2026: AI stocks outlook

Pre-market ISRG stock trades at $472.16 on NASDAQ on Mar 16 2026, down -1.48% from yesterday’s close. The immediate move tracks a reported cybersecurity incident and ongoing rotation in healthcare AI names. We use Meyka AI-powered market analysis platform data to link price action to valuation, technicals, and forecast models for Intuitive Surgical, Inc. (ISRG) in the United States (USD). This piece focuses on what the market is pricing, upcoming catalysts, and model-based targets.

ISRG stock: Pre-market snapshot

ISRG (Intuitive Surgical, Inc.) is trading $472.16 pre-market on NASDAQ with a -1.48% one-day move. Volume sits at 2,489,201 shares versus average 1,922,001, and intraday range is $458.00–$482.68. Key metrics: EPS $7.89, PE 59.84, market cap $167,678,292,702. Traders should note the 50-day average $517.42 and 200-day average $511.65, which act as near-term resistance levels.

ISRG stock news and catalysts

The stock slipped after Intuitive reported a cybersecurity incident, which prompted selling in the healthcare technology space. See the incident coverage source.

Upcoming catalyst: the company lists an earnings announcement on 2026-04-21. Analyst sentiment shows 16 buys, 4 holds, 2 sells (consensus 3.00). For ongoing headlines and quotes, see the ISRG quote page source. Each item ties to near-term volatility ahead of the earnings release.

ISRG stock: Financials and valuation

Intuitive’s fundamentals show margin strength and cash generation, with net income per share $8.05, operating cash flow per share $8.54, and free cash flow per share $7.02. Price-to-sales is 16.62, price-to-book 9.38, and free cash flow yield about 1.49%. Revenue growth for FY 2024 was 17.24%, and R&D sits near 13.03% of revenue. High multiples reflect market expectations for continued robotics adoption and service revenues.

ISRG stock: Technicals and trading levels

Technical indicators are tilted toward short-term weakness. RSI is 37.61, MACD histogram slightly negative, and ADX 28.32 shows a defined trend. Key intraday support is $458.00 and resistance near $482.68, with moving-average overhead at $517.42 (50-day). ATR is $13.48, and on-balance volume is negative, suggesting selling pressure. Traders using trend-following signals should watch for a break above $495.00–$510.00 to regain a bullish bias.

Meyka Grade, analyst context and ISRG stock forecast

Meyka AI rates ISRG with a score out of 100: 79.78 — Grade B+ — Suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.

Meyka AI’s forecast model projects monthly $438.35, quarterly $485.77, and yearly $585.45. Versus the current price $472.16, that implies a short-term downside of -7.17% to the monthly model, a near-term upside of +2.88% to the quarterly model, and a 12-month implied upside of +24.01% to the yearly model. Forecasts are model-based projections and not guarantees.

ISRG stock: Investment thesis and risks

Thesis: Intuitive remains a leader in surgical robotics and benefits from recurring service revenue, instrument sales, and expansion into diagnostic tools like the Ion system. AI and digital workflow upgrades support long-term adoption and program-level economics for hospitals.

Risks: premium valuation (PE near 59.84), execution and competitive pressure, regulatory scrutiny, and operational disruptions such as cyber incidents. For AI stocks exposure, position sizing and stop methodology should reflect higher volatility around earnings and news events. See company site for product details Meyka ISRG page.

Final Thoughts

ISRG stock trades at $472.16 pre-market on Mar 16 2026 amid headlines and a cyber incident that added short-term pressure. Fundamentals remain healthy: strong cash flow per share and double-digit revenue growth support a premium multiple. Meyka AI’s model projects a yearly target of $585.45, implying +24.01% upside from the current price, while the monthly model sits at $438.35 implying -7.17% near-term risk. Technicals show RSI 37.61 and overhead resistance at the 50-day average $517.42. In summary, ISRG offers long-term upside tied to AI-driven surgical adoption but carries valuation and event-driven risks. Use defined risk limits ahead of the April 21, 2026 earnings report and follow evolving news flow for guidance from both company releases and market signals. Meyka AI provides this analysis as an AI-powered market analysis platform; forecasts and grades are projections, not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.